SCHEMBL31476147

SCHEMBL31476147

COc1cc(N)ccc1Oc1ccc2c(c1)ncn2C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
FGFR1 P11362 2/20 0.49
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
KMT2A Q03164 3/20 0.48
GAA P10253 3/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 3/20 0.43
PRNP P04156 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 2/20 0.41
KDR P35968 1/20 0.41
THRB P10828 1/20 0.41
PKM P14618 1/20 0.41
GRM5 P41594 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
DDB1 Q16531 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23750375 1.00 MAPT (0.49) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL1191996 0.86 KMT2A (0.46) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL31351997 0.85 KMT2A (0.43) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL23750359 0.85 KMT2A (0.43) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL29888756 0.85 KMT2A (0.43) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL23750376 0.85 KMT2A (0.43) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL23750358 0.85 KMT2A (0.43) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL24569506 0.82 FGFR1 (0.54) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL23750374 0.81 KMT2A (0.41) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL31257582 0.80 KMT2A (0.44) MAPTFGFR1ALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129078-A1 ERBB2 INHIBITORS COGENT BIOSCIENCES, INC. 2025-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129078-A1 ERBB2 INHIBITORS ERBB2, ERBB3, EGFR MAPT 72/4885FGFR1 18/4885ALDH1A1 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.